Here's Why Editas Medicine Gained as Much as 14.2% Today [The Motley Fool]
JUNO THERAPEUTICS (JUNO)
Last juno therapeutics earnings: 11/1 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.junotherapeutics.com/investor-relations
Company Research
Source: The Motley Fool
Finally, a stock that actually deserves to move on the Juno Therapeutics acquisition news. Maxx Chatsko ( TMFBlacknGold ) Jan 22, 2018 at 4:27PM What happened Shares of gene-editing pioneer Editas Medicine ( NASDAQ:EDIT ) rose over 14% today after Celgene ( NASDAQ:CELG ) announced it will acquire the remaining 90% of Juno Therapeutics ( NASDAQ:JUNO ) it didn't already own. The $9 billion blockbuster deal is just the latest in the biopharma sector for companies developing novel chimeric antigen receptor T-cell (CAR-T) and T-cell receptor (TCR) therapies as potential cancer treatments. What's the big deal for Editas Medicine? While many stocks are moving on today's news simply because they're developing unrelated CAR-T therapies, the gene-editing pioneer is actually partnered with Juno Therapeutics. The goal of the partnership is
Show less
Read more
Impact Snapshot
Event Time:
JUNO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JUNO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JUNO alerts
High impacting JUNO THERAPEUTICS news events
Weekly update
A roundup of the hottest topics